However, TNF-α-induced activation of the transcription factor nuclear factor- (NF-) κB and NF-κB-driven expression of prosurvival factors is a major obstacle to preventing the cancer therapeutic efficacy of TNF-α. This evidence concerns the gene NFKB1 and cancer.